{"id":11586,"date":"2018-12-20T15:11:19","date_gmt":"2018-12-20T14:11:19","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=11586"},"modified":"2018-12-20T15:15:38","modified_gmt":"2018-12-20T14:15:38","slug":"nuova-joint-venture-gsk-pfizer-per-la-sanita","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/","title":{"rendered":"Nuova joint venture GSK-Pfizer per la sanit\u00e0"},"content":{"rendered":"\n<p>Photo by  Roman Kraft  <\/p>\n\n\n\n<p>I due colossi farmaceutici sono giunti ad un accordo per la creazione di una joint venture nel settore della sanit\u00e0. La nuova societ\u00e0, in cui GSK avr\u00e0 la maggioranza (il 68%), conter\u00e0 su un fatturato di 9,8 miliardi di sterline.   GlaxoSmithKline ha dichiarato in particolare che l\u2019accordo ha posto le basi per la creazione di due nuove societ\u00e0 globali con HQ nel Regno Unito e focalizzate su prodotti farmaceutici, vaccini e assistenza sanitaria ai consumatori. La nuova societ\u00e0 sar\u00e0 quotata sul mercato azionario entro tre anni. <\/p>\n\n\n\n<p> \u00abLa nuova Joint Venture sar\u00e0 ben posizionata per offrire maggiori  vendite, cash flow e crescita degli utili\u00bb, ha spiegato Glaxo. La combinazione unir\u00e0 insieme due portafogli complementari, con marchi importanti in area consumer healthcare, tra cui Sensodyne di GSK, Voltaren e Panadol e Pfizer Advil, Centrum e Caltrate. La joint venture sar\u00e0 inoltre leader di categoria in altri settori,  come quello degli adiuvanti respiratori, vitaminici e minerali, digestivi, salute della pelle e della salute orale terapeutica. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Photo by Roman Kraft I due colossi farmaceutici sono giunti ad un accordo per la creazione di una joint venture nel settore della sanit\u00e0. La nuova societ\u00e0, in cui GSK avr\u00e0 la maggioranza (il 68%), conter\u00e0 su un fatturato di 9,8 miliardi di sterline. GlaxoSmithKline ha dichiarato in particolare che l\u2019accordo ha posto le basi per la creazione di due nuove societ\u00e0 globali con HQ nel Regno Unito e focalizzate su prodotti farmaceutici, vaccini e assistenza sanitaria ai consumatori. La&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":11587,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[],"class_list":["post-11586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"Photo by Roman Kraft I due colossi farmaceutici sono giunti ad un accordo per la creazione di una joint venture nel settore della sanit\u00e0. La nuova societ\u00e0, in cui GSK avr\u00e0 la maggioranza (il 68%), conter\u00e0 su un fatturato di 9,8 miliardi di sterline. GlaxoSmithKline ha dichiarato in particolare che l\u2019accordo ha posto le basi per la creazione di due nuove societ\u00e0 globali con HQ nel Regno Unito e focalizzate su prodotti farmaceutici, vaccini e assistenza sanitaria ai consumatori. La...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-20T14:11:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-12-20T14:15:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Nuova joint venture GSK-Pfizer per la sanit\u00e0\",\"datePublished\":\"2018-12-20T14:11:19+00:00\",\"dateModified\":\"2018-12-20T14:15:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/\"},\"wordCount\":172,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/roman-kraft-266787-unsplash-e1545315019489.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/\",\"name\":\"Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/roman-kraft-266787-unsplash-e1545315019489.jpg\",\"datePublished\":\"2018-12-20T14:11:19+00:00\",\"dateModified\":\"2018-12-20T14:15:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/roman-kraft-266787-unsplash-e1545315019489.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/roman-kraft-266787-unsplash-e1545315019489.jpg\",\"width\":1000,\"height\":667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/nuova-joint-venture-gsk-pfizer-per-la-sanita\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuova joint venture GSK-Pfizer per la sanit\u00e0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/","og_locale":"en_US","og_type":"article","og_title":"Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners","og_description":"Photo by Roman Kraft I due colossi farmaceutici sono giunti ad un accordo per la creazione di una joint venture nel settore della sanit\u00e0. La nuova societ\u00e0, in cui GSK avr\u00e0 la maggioranza (il 68%), conter\u00e0 su un fatturato di 9,8 miliardi di sterline. GlaxoSmithKline ha dichiarato in particolare che l\u2019accordo ha posto le basi per la creazione di due nuove societ\u00e0 globali con HQ nel Regno Unito e focalizzate su prodotti farmaceutici, vaccini e assistenza sanitaria ai consumatori. La...","og_url":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/","og_site_name":"Frezza Partners","article_published_time":"2018-12-20T14:11:19+00:00","article_modified_time":"2018-12-20T14:15:38+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Nuova joint venture GSK-Pfizer per la sanit\u00e0","datePublished":"2018-12-20T14:11:19+00:00","dateModified":"2018-12-20T14:15:38+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/"},"wordCount":172,"commentCount":0,"image":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/","url":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/","name":"Nuova joint venture GSK-Pfizer per la sanit\u00e0 - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg","datePublished":"2018-12-20T14:11:19+00:00","dateModified":"2018-12-20T14:15:38+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/12\/roman-kraft-266787-unsplash-e1545315019489.jpg","width":1000,"height":667},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/nuova-joint-venture-gsk-pfizer-per-la-sanita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Nuova joint venture GSK-Pfizer per la sanit\u00e0"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/11586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=11586"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/11586\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/11587"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=11586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=11586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=11586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}